- Novartis, GSK explore African genetic diversity for malaria, TB treatment
- Jianshun Biosciences, Etta Biotech focus on high quality protein production
- Genesis Medtech collaborates with Penumbra to expand Neurovascular market in China
- Novel Robotic Gamma probe approved for intra-operative lymph node & cancer detection
- Korean scientists invent Nanocrystals that Eradicate Bacteria Biofilm
- New U Life pre-launches healthcare products in NZ, Australia
- Innovent Out-license Biosimilar development and commercialization rights in Indonesia
- TenNor, Janssen plan new treatments for non-tuberculous mycobacteria diseases
- Taiwan develops TeleRehabilitation system providing comprehensive training and tools
- Scientists address vaccine safety & efficacy at global R&D forum
- Medtec China 2021 to exhibits advanced medical equipment & manufacturing services
- Mitsubishi Tanabe & Takeda to accelerate data-driven drug discovery
- Singapore designs armoured anti-cancer T cells against immunosuppressants
- Fujifilm injects $76M into manufacturing and innovation centre
-
North America | 04 January 2021 | Opinion
“We are planning to launch a new bioprocess controller in Q1 2021”
Their applications are diverse, and the products can be found in pharmaceutical, chemical, and nutrition indus...Read more
Korea | 07 December 2020 | News
Samsung Biologics drives digital transformation with Plant 4 Virtual Showroom launch
Samsung Biologics announced the launch of a virtual showroom to provide key features and real-time constructio...Read more
-
CMC & Manufacturing | 06 November 2020 | News
Thermo Fisher to establish new pharma services facility in China
Thermo Fisher Scientific Inc. has signed a joint venture agreement to establish a new pharma services facility...Read more
-
Korea | 26 November 2020 | News
Korea inks MoU with Ecuador for global health R&D
The International Vaccine Institute (IVI) and Ministry of Foreign Affairs and Human Mobility of Ecuador exchan...Read more
World | 08 December 2020 | News
Merck expands life science production capacities in US
Merck, a leading science and technology company, has announced the broadening of its manufacturing footprint w...Read more
-
Japan | 25 November 2020 | News
Japan's Fujitsu drives digital transformation in hospitals and clinics
Fujitsu on 25 Nov 2020 announced the commercial debut of its "FUJITSU Healthcare Solution Online Healthcare So...Read more
-
China | 25 November 2020 | Company results
I-Mab reports efficacy of Anti-CD47 monoclonal Ab on relapsed/refractory malignancy
I-Mab, a global clinical-stage biopharmaceutical company based in China and the US and committed to the discov...Read more
2021 beckbones Major Investment in R & D
The life sciences industry in Asia Pacific (APAC) region entered the year 2020 with companies entering into new agreements for expansion and focusing on applied research to develop new drugs that are affordable. During 2020, the industry, which acted timely, as covered in the January 2020 issue of BioSpectrum Asia, witnessed unprecedented collaborations with the governments due to the unexpected spread of coronavirus since December 2019. COVID-19 is expected to remain a defining issue for the life sciences industry across the globe in 2021, compelling companies to invest heavily in research and development
For Feedback Email Us : communications@biospectrumasia.com
